-->

Tag: Biliary Tract Cancer Treatment

Home / Biliary Tract Cancer Treatment

Categories

Zanidatamab-hrii is approved by the USFDA for previously treated unresectable or metastatic HER2-positive biliary tract cancer

 On November 20, 2024, the Food and Drug Administration granted accelerated approval for zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals, Inc.), a bispecific HER2-targeted antibody, for previously tr...
biliary-tract-cancer-treatment

bile duct cancer radiotherapy


biliary-tract-cancer-treatment

Scan the code